Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant

Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant

Abstract The impact of pre‐transplant anti‐severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) vaccine in 20 recipients of allogeneic hematopoietic stem cell transplantation (Allo‐HSCT) and/or their donors is reported here, showing that the persistence of anti‐SARS‐CoV‐2 antibodies can be d...

Full description

Bibliographic Details
Main Authors: Maxime Jullien, Marianne Coste‐Burel, Beatrice Clemenceau, Valentin Letailleur, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Berthe‐Marie Imbert, Jocelyn Ollier, Audrey Grain, Cyrille Touzeau, Philippe Moreau, Marie C Béné, Henri Vié, Patrice Chevallier
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:eJHaem
Subjects:
allogeneic
cellular response
COVID‐19
hematological
humoral response
SARS‐CoV‐2 mRNA
Online Access:https://doi.org/10.1002/jha2.398

Internet

https://doi.org/10.1002/jha2.398

Similar Items